Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT05220319Phase 4Completed
Phase 4, randomised trial in muscle weakness and Systemic Inflammatory Response Syndrome (SIRS) comparing Placebo with Methylprednisolone (2 arms). Primary endpoint: Post operative muscle weakness. Started Feb 2022; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT05220319.